Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. Cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant.Colorectal cancer diagnostic market segmented on the basis of test, end-users and geographical regions.
Based on Test Type, the colorectal cancer diagnostic market is segmented as FOB, CTC, CEA, immunohistochemistry, KRAS mutation tests, and others. FOB tests will remain the largest adopted tests for colorectal cancer diagnostics across the globe. In addition, FOB tests in the global colorectal cancer diagnostics market will account for the largest revenues, followed by CTC tests. The factors which influence the growth of the market include technological advancements in radiology & chemotherapy, increasing cancer prevention initiatives, and others.
Based on end-user type, colorectal cancer diagnostic market is segmented into hospitals, diagnostic centers, cancer research institutes and others. It has been found that due to adoption of technologically advanced diagnostic devices hospitals and diagnostic centers are dominating the market.
Read more Insights at [URL]https://precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/[/URL]
Precision Business Insights (PBI), colorectal cancer diagnostic market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share due to increased rates of colorectal cancers and technological advancements in the diagnosis of cancers.
Launch of Advanced technologies in Colorectal Cancer Diagnostic Market
In May 2015, EKF Diagnostics Holdings plc. launched its next-generation sequencing technology Precision Path in partnership with Greenville Health Systems to test the colon cancer. Key player’s profiles in the report are Illumina, Inc., Sysmex Corporation, Danaher Corporation, Rosetta Genomics, Epigenomics AG, Exact Science Corporation, Pathway Genomics Corporation, Biocept, Inc., Cancer Genetics, Inc., and Foundation Medicine, Inc.
Download free sample report at [URL]https://precisionbusinessinsights.com/request-sample?product_id=22313[/URL]
Detailed Segmentation
By Test Type
o CEA Tests
o FOB
o CTC Tests
o KRAS mutation Tests
o Others
By End-User Type
o Diagnostic centers
o Hospitals
o Cancer research institutes
Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @www.precisionbusinessinsights.com